Clinical trial

A Study for Tysabri Participant Preference

NCT05304520

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-10-12

PhaseN/A

Study timeline

Study start (actual)2021-10-12Date precision: day

Registry last updated2024-05-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-Remitting Multiple Sclerosis (RRMS)unresolved

Interventions

NatalizumabDRUG

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

BerlinGermany5 MünchenGermany2 MannheimGermany2 EssenGermany1 UlmGermany1 DüsseldorfGermany1 BonnGermany1 ErlangenGermany1 BochumGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05304520 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.